Costs are spiking in the traditional Chinese medicine sector due to the nation’s reliance on China for ingredients, a China Medical University professor said on Friday.
The prices of some traditional Chinese medicine products have risen three to five times their original prices, while others are in short supply, such as goldthread and Manchurian wild ginger, pharmacy professor Huang Shyh-shyun (黃世勳) said.
“The main problem is the high reliance on China for imports of traditional Chinese medicine. Taiwan should source its ingredients from other countries,” Huang said.
Photo: Taipei Times file
The government should develop “Taiwanese traditional medicine” by researching alternative ingredients or sources outside of China to prevent shortages, he said.
For example, Wolfiporia extensa — a medicinal mushroom also known as poria — was mainly imported from China’s Fujian Province, but is now also imported from South Africa, while Chinese licorice was previously imported from Xinjiang, but is now mostly imported from Pakistan, he said.
“In Taiwan, we conduct tests and quality control checks on all imported herbal medicine. We found that the quality [of these products] is on the same level as those from China,” he said.
While the Compendium of Materia Medica (本草綱目), a Ming
Dynasty-era encyclopedia of herbal medicine, lists 1,892 items, traditional Chinese medicine practitioners usually only use about 400 to 500 ingredients, Huang said.
“There is more medicinal knowledge recorded in other ancient texts, so we still have plenty of room for improvement, to find single ingredients with many uses,” he said.
Practitioners can also consider alternative ingredients for treatments, such as the underground stem of the Onychium japonicum, a fern that grows in Taiwan, to replace goldthread, he said.
Although not often used in traditional Chinese medicine, creeping woodsorrel (Oxalis corniculata) has anti-inflammatory properties, while Angelica acutiloba — which is used in traditional medicine in Japan — can be used in place of female ginseng (Angelica sinensis), he said.
However, A acutiloba is not listed in the Ministry of Health and Welfare’s Taiwan Herbal Pharmacopeia (台灣中藥典), which is updated every five years, most recently last year.
“If it is not listed there, then it cannot be prescribed by traditional Chinese medicine practitioners in Taiwan,” Huang said, adding that it could still be used as a cooking ingredient.
“The government should help develop the use of domestic plants and herbal materials, and research how these can be used in traditional Chinese medicine,” he said.
Meanwhile, traditional Chinese medicine practitioners must research multiple uses for already available ingredients to develop replacements, he added.
“Only then can we lower our reliance on traditional Chinese medicine from China,” he said.
Eighty-six percent of Taiwan’s traditional Chinese medicine products are imported from China, Department of Chinese Medicine Director-General Huang Yi-tsau (黃怡超) said.
The government is working with New Southbound Policy countries to find alternate sources, he said.
The government has also allocated NT$4 million (US$128,193) to implement a program for cultivating traditional Chinese medicinal plants, he added.
Considering that most countries issue more than five denominations of banknotes, the central bank has decided to redesign all five denominations, the bank said as it prepares for the first major overhaul of the banknotes in more than 24 years. Central bank Governor Yang Chin-lung (楊金龍) is expected to report to the Legislative Yuan today on the bank’s operations and the redesign’s progress. The bank in a report sent to the legislature ahead of today’s meeting said it had commissioned a survey on the public’s preferences. Survey results showed that NT$100 and NT$1,000 banknotes are the most commonly used, while NT$200 and NT$2,000
The Centers for Disease Control (CDC) yesterday reported the first case of a new COVID-19 subvariant — BA.3.2 — in a 10-year-old Singaporean girl who had a fever upon arrival in Taiwan and tested positive for the disease. The girl left Taiwan on March 20 and the case did not have a direct impact on the local community, it said. The WHO added the BA.3.2 strain to its list of Variants Under Monitoring in December last year, but this was the first imported case of the COVID-19 variant in Taiwan, CDC Deputy Director-General Lin Ming-cheng (林明誠) said. The girl arrived in Taiwan on
South Korea is planning to revise its controversial electronic arrival card, a step Taiwanese officials said prompted them to hold off on planned retaliatory measures, a South Korean media report said yesterday. A Yonhap News Agency report said that the South Korean Ministry of Foreign Affairs is planning to remove the “previous departure place” and “next destination” fields from its e-arrival card system. The plan, reached after interagency consultations, is under review and aims to simplify entry procedures and align the electronic form with the paper version, a South Korean ministry official said. The fields — which appeared only on the electronic form
The Ministry of Foreign Affairs (MOFA) is suspending retaliation measures against South Korea that were set to take effect tomorrow, after Seoul said it is updating its e-arrival system, MOFA said today. The measures were to be a new round of retaliation after Taiwan on March 1 changed South Korea's designation on government-issued alien resident certificates held by South Korean nationals to "South Korea” from the "Republic of Korea," the country’s official name. The move came after months of protests to Seoul over its listing of Taiwan as "China (Taiwan)" in dropdown menus on its new online immigration entry system. MOFA last week